Scandidos
1,69 SEK -3,43%Vær den første som følger denne virksomhed
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Omsætning
61,5 mio.
EBIT %
-13,38 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SDOS
Daglig lav / høj pris
1,69 / 1,85
SEK
Markedsværdi
96,35 mio. SEK
Aktieomsætning
195,24 t SEK
Volumen
113 t
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Spore Invest AB | 27,4 % | 27,4 % |
Commerzbank AG, W8IMY - IBA Dosimetry | 10,1 % | 10,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
ScandiDos receives orders worth €478 000 from China
ScandiDos AB changes Certified Adviser and liquidity provider to Carnegie Investment Bank AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools